Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1699382 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.07Day −2.73%Mkt cap $57M1Y −25.7%Off 52W high −43.1%Vol (1Y) 71.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,360 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.5% of sh out |
| Days to cover6.3d |
| 13F net flow (QoQ)+0.24% |
| Top-10 13F concentration76.9% |
| Next report (est.)2026-08-11 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$78.3M |
| ROE−55.4% |
| ROIC−67.5% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−14.4% |
| 1Y−25.7% |
| 3Y−83.6% |
| 5Y−96.9% |
| Since incept. (ann.)−48.9% |
Total return through 2026-07-29 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)71.1% |
| Ann. volatility (3Y)78.3% |
| Sharpe (1Y)−0.15 |
| Sharpe (3Y)−0.38 |
| Max drawdown (1Y)−41.1% |
| Max drawdown (3Y)−90.6% |
| Beta (3Y vs SPY)2.27 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BML Capital Management, LLC | 5.3M | $7M | 9.98% | +0.5% |
| TANG CAPITAL MANAGEMENT LLC | 4.2M | $5M | 7.96% | −14.1% |
| Sio Capital Management, LLC | 3.1M | $4M | 5.77% | +16.7% |
| ArrowMark Colorado Holdings LLC | 2.9M | $4M | 5.39% | −7.0% |
| Euclidean Capital LLC | 2.6M | $3M | 4.93% | +0.0% |
| Eversept Partners, LP | 2.3M | $3M | 4.40% | new |
| ACADIAN ASSET MANAGEMENT LLC | 2.2M | $3M | 4.15% | +9.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $2M | 3.70% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$0.34 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$0.40 | — | — | — |
| 2025-06-30 | 2025-08-07 | −$0.41 | — | — | — |
| 2025-03-31 | 2025-05-09 | −$0.34 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-11 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
